high definition diagnostics℠

Technology Designed to Reveal More

Simoa's revolutionary digital approach to immunoassays allows single molecules to be counted, delivering a roughly 1000-fold increase in sensitivity. This remarkable sensitivity combined with full automation unlocks a world of insight into disease detection, diagnosis, and patient treatment while meeting the demands of today's laboratory.

 
 

Unprecedented Sensitivity

1000 times greater sensitivity than conventional immunoassays.
Learn More.

 

Robust Multiplexing

Improve efficiencies and stretch samples with up to 10-plex assays.
Learn More.

 

Complete Automation

Sample in, result out with an intuitive, user-friendly interface.
Learn More.

Keep up with Kevin

Hear from our innovative thought leader, Kevin Hrusovsky, Quanterix' Executive Chairman, on Twitter (@KevinHrusovsky) and connect with him on LinkedIn for thought provoking commentary and insights as he discusses and shares ways to eradicate disease and promote personalized healthcare.

 

Trauma Test: Concussions in athletes

WHDH.com Boston Channel 7, reported by Joe Amorosino


Read the full article

Powering Precision Health Summit 2016

What: Powering Precision Health Summit 2016
When: Monday, September 26, 2016 9:00am - 5:00pm ET
Where: Boston Marriott Cambridge, 50 Broadway, Cambridge, MA USA
Email for more information: This email address is being protected from spambots. You need JavaScript enabled to view it.
Registration: http://www.pphsummit.com/register.html

Platinum Sponsor: Quanterix
Founded by our CEO Kevin Hrusovsky

Quanterix in the News

  • 01 Aug 2016 — 

    Quanterix and Banyan Biomarkers Join Together to Address Traumatic Brain Injury Head On

    Read More
  • 15 Jun 2016 — 

    Frontage Laboratories Announces Partnership with Quanterix and Validation of Simoa HD-1 Analyzer and Software to Support Biomarker Analysis

    Read More
  • 24 May 2016 — 

    Quanterix to Present at 5th Annual One Mind Summit

    Read More

Recent Publications